Exact Sciences Corp

EXAS NASDAQ Santé & Biotech États-Unis US30063P1057
104.91 $

Exact Sciences Corp se spécialise dans le développement de tests de dépistage du cancer non invasifs, en particulier pour le cancer colorectal.

Performance & Momentum

6 Months 4.21 %
1 Year 81.47 %
3 Years 25.48 %
5 Years 1.30 %

Similar stocks to Exact Sciences Corp

Anantys Community

Be the first to share your analysis on Exact Sciences Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases